Dudediligence.

Immunic, Inc

IMUXNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

13.6M

on 2026-06-30, from 9.01M on 2024-03-31 10-Q ↗

Earlier counts are adjusted for the 1-for-10 reverse split; each bar's tip shows the count as filed.

a raise that quarter, at its price

Newest

None

No S-3 or F-3 shelf on file in the last 30 months.

3 of its filings are not read yet.

Warrants

The 10-Q filed 2026-08-11 is not read yet.

Cash

7.1 quarters

$155.1M on 2026-06-30 ÷ $21.9M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2026-02-12Private placementnot readnot read$200.0M8-K ↗
2025-05-28Public offeringnot read$0.7499$65.0M424B5 ↗
2025-04-09Private placement5,666,667not read$5.1M8-K ↗
2025-04-09Public offering5,666,667$0.90$5.1M424B5 ↗

Also on file: a 1-for-10 reverse split, 2026-04-22 8-K ↗